CV | Moradi MD

Education

2017 – Master of Business Administration (MBA), Wharton University of Pennsylvania School of Business
1995–1999 – Head & Neck Surgery Residency, Duke University Medical Center
1994 – Doctor of Medicine, University of California San Diego Medical School; Honors
1989 – Bachelor of Science: Biological Sciences, University of California, San Diego; Summa Cum Laude

Medical Licensure

California State Medical License
North Carolina State Medical License
Nevada State Medical License

Certification

Board Certified, American Board of Facial Plastic & Reconstructive Surgery
Board Certified, American Academy of Otolaryngology Head & Neck Surgery
Good Clinical Practices

Professional Experience

Pacific Clinical Innovations Inc. (2024–Present)

CEO, Principal Investigator

UC San Diego School of Medicine (2005 - Present)

Clinical Instructor of Anatomy

Moradi MD (2000–Present)

CEO, Medical Director

Professional Memberships

American Academy of Facial Plastic & Reconstructive Surgery
California Medical Society
Association of Clinical Research Professionals
American Society of Laser Medicine & Surgery
California Society of Facial Plastic Surgery

Scale Development And Validation

2025 Merz Masseter Prominence Scale
2025 Canfield Cheek Smoothness and Fine Line Scale
2024 Medytox Facial Wrinkles Scale
2024 Teoxane Lip and Midface Scales
2024 Allergan Crepey Skin Scale
2023 Allergan 2D Monile Image Validation
2023 Canfield Jawline and Chin Scales
2023 Galderma Cellulate Scale
2023 Canfield Hip Dip Scale
2022 Teoxane Jawline, Chin, and Hand Scales
2022- Canfeild Infraorbital Hollows, Nasal Labial Folds, Upper and Lower Lip, Chin

2022 Allergan Mid Face Volume Defecit Scale
2021 Lifesprout Midface Scale
2020 Galderma Jawline Scale
2019 Galderma Lateral Canthal Line Scale
2019 Galderma Forehead line scale
2019 Galderma Glabella line scale
2018 Galderma Chin Retrusion Scale
2017 Galderma Decollotage Scale
2017 Merz Jawline Scale
2016 Merz Cheek Scale
2016 Galderma Temple Scale

Industry Experience

2023-Present: Board of Directors and Treasurer- California Pacific Society of Facial
Plastic Surgeons
2016-2018: Board of Directors – CAP MPT
2010-2018: CAP-MPT Cosmetic Procedures Committee
2008-2018: Face to Face Committee – American Academy of Facial Plastic Surgery
Regulatory and Socioeconomic Affairs Committee – American Academy of Facial Plastic Surgery
Patient Safety Committee – American Academy of Facial Plastic Surgery

Hospital Privileges

Tri City Medical Center, Oceanside, CA (Facial Plastic Surgery)
Scripps Memorial Hospital, La Jolla, CA (Facial Plastic Surgery)

Honors and Awards

1994 – The Hamburger Award for best student independent study project: ICG-a and Angiofibroma
1991 – NIH Student Summer Research Grant
1993 – American Medical Association Educational Research Foundation Grant
1994 – Excellence in Research Award – Western Medical Research Committee

Disclosures

Allergan – Consultant, Advisory Board, Faculty, Clinical Research Investigator
Merz Aesthetics – Consultant, Advisory Board, Member of Steering Committee, Clinical Research Investigator
Galderma – Consultant, Advisory Board, Clinical Research Investigator
L'Oréal – Consultant, Clinical Research Investigator
Skin Medica – Consultant, Advisory Board, Clinical Research Investigator
BTL – Consultant, Speaker, Clinical Research Investigator
Lutronic – Consultant, Speaker, Clinical Research Investigator
Alastin – Consultant, Clinical Research Investigator
Evolus – Consultant, Clinical Research Investigator
Recros Medica – Clinical Research Investigator
GloPharma (Ourself) – Consultant, Clinical Research Investigator, Stockholder
Teoxane – Advisory Board, Consultant
Symatase – Clinical Research Investigator
Canfield – Consultant
Veramdermics – Clinical Research Investigator

Research

An open-label, multicenter, single-arm, uncontrolled safety study to assess radiographic imaging following treatment with RADIESSE® dilute in the décolleté in adult females in the United States. July 2025-Present (Principal Investigator)
Study to Collect Post-Market Data on Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas with the CoolSculpting Elite System. July 2025-present (Principal Investigator)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Dose Study to Evaluate the Efficacy and Safety of VDPHL01 in Female Subjects With Androgenetic Alopecia. June 2025- Present (Principal Investigator)
A Prospective, multicenter, randomized, double blind study to evaluate safety and effectiveness of Juläine for nasolabial fold augmentation in comparison to Sculptra®. June 2025-Present (Principal Investigator)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients with Moderate to Severe Atopic Dermatitis. June 2025-Present (Principal Investigator)
US HARMONY in DIVERSITY: A Prospective, Open-label Study to Evaluate Subject Satisfaction with the Overall Face and Neck Appearance After Combined Treatment. January 2024-Present (Principal Investigator)
A randomized, double-blind, placebo-controlled, parallel group, multi-dose study to evaluate the efficacy and safety of VDPHL01 in male subjects with Androgenetic Alopecia. November 2024-Present (Principal Investigator)
A monocenter, double blinded study to evaluate the skin rejuvenation and anti-aging benefits of two topical periorbital eye formulation post ProFractional® Laser Resurfacing procedure. October 2024-August 2025 (Principal Investigator)
A single center, split face, placebo-controlled, double-blind randomized study to assess the efficacy and tolerability of a novel topical cosmetic product or regimen in subjects that have received a Sofwave treatment in the lower face and neck. October 2024-August 2025 (Principal Investigator)
A Multi-Center, Open-label Clinical Trial Evaluating a Plant Adaptogen Serum for Improvement in Facial Skin Quality in Females Impacted by Hormonal Decline. September 2024-June 2025 (Principal Investigator)
A single center, open label study to assess the efficacy and tolerability of a novel topical cosmetic product in subjects that have received neurotoxin injections in the face. August 2024-January2024 (Principal Investigator)
A Multi-Center, Double-Blinded, Randomized, Non-Inferiority Study to Evaluate the Safety and Effectiveness of EvolysseTM Lips for Lip Augmentation. July 2024-Present (Principal Investigator)
A randomized, evaluator-blinded, parallel group, comparator-controlled, multicenter study to evaluate the safety and effectiveness of GP0121 in lip augmentation and correction of perioral area. May 2024- Present (Principal Investigator)
Botox® (onabotulinumtoxinA) for the reduction of masseter muscle prominence: a phase 3, multicenter, randomized, double-blind, placebo- controlled study. May 2024- present (Principal Investigator)
A prospective, multi-center, open label study to evaluate subject satisfaction and natural outcomes following administration of Botox® Cosmetic (Botulinum Toxin Type A) purified neurotoxin complex in subjects with upper facial lines (glabella lines, lateral canthal lines, and forehead lines) April 2024- February 2025 (Principal Investigator)
A split face, single center study to evaluate the efficacy of HA+ replenishing eye serum in subjects receiving a pre-elected upper blepharoplasty. April 2024- October 2024 (Principal Investigator)
A single center, open-label study to assess the efficacy and tolerability of a topical cosmetic hydrating serum in subjects who received a pre-elected cosmetic facial injection or microneedling procedure. April 2024- November 2024 (Principal Investigator)
A randomized, evaluator-blinded, parallel group, comparator controlled, multicenter study to evaluate the safety and effectiveness of GP0116 for correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds. March 2024-present (Principal Investigator)
A double blinded placebo controlled clinical study to evaluate the efficacy and tolerability of a lip plumping product used in individuals who have had previous lip augmentation using hyaluronic acid filler (within 3-9 months) and desire fuller lips. Jan 2024-July 2024 (Principal Investigator)
A multicenter real-world evidence study with retrospective chart review and cross-sectional survey to evaluate the satisfaction and benefits of long-term repeated BOTOX treatment for upper facial lines Dec 2023-February 2025 (Principal Investigator)
A Randomized, Blinded Evaluator, No-Treatment Control, Multicenter, Prospective, Clinical Study of RHA®4 for the Correction of Sagging Jawline Oct 2023-Present (Principal Investigator)
A Prospective, Randomized, Double‐Blind, Split‐Face Trial Evaluating the Effects of Pre‐Conditioning with A TriHex Technology® Serum Nectar 2.0 Vs A Vehicle in Subjects Undergoing Elective Facelift Surgery Oct 2023-October 2024 (Principal Investigator)
Clinical study to evaluate efficacy and tolerability of an antioxidant serum with vitamin C for moderate to severe facial photodamage Mar 2023-Sep2023 (Principal Investigator)
A randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane Contour in the treatment of temple hollowing Mar 2023-January 2025 (Principal Investigator)
A prospective, multicenter, randomized, comparator-controlled, evaluator-blinded study to evaluate the safety and effectiveness of Belotero® Intense Lidocaine for lip augmentation. Mar 2023-January 2025 (Principal Investigator)
Revalidation of the Mid-Face Volume Deficit Scale” Febuary 2023-May 2023 (Principal Investigator)
A clinical study to evaluate the benefits of a topical hyaluronic acid facial product July 2022-October 2022 (Principal Investigator)
A prospective, multi-center, randomized, controlled, blinded study of the effectiveness of Precise Sculpt Dermal Filler to correct age-related volume deficit in the mid-face July 2022-Present (Principal Investigator)
A prospective clinical study to evaluate safety and effectiveness of Restylane Kysse for lip augmentation in Chinese subjects June 2022-Dec 2023 (Principal Investigator)
A phase 3b, randomized, double-blind, placebo-controlled study to assess aesthetic improvement and onset of QM1114-DP Treatment effect in subjects with moderate to severe glabellar Lines May 2022-Oct 2023 (Principal Investigator)
A Phase 3 multicenter, randomized, double blind, placebo-controlled study to evaluate the safety and efficacy of BOTOX (botulinum toxin type A) purified neurotoxin complex for the treatment of platysmal prominence May 2022-2023 (Principal Investigator)
Noninvasive fat reduction with the CoolSculpting system Apr 2022-Feb 2023 (Principal Investigator)
Clinical study to evaluate efficacy and tolerability of a cosmetic formulation that improves the appearance of crow’s feet wrinkles April-June 2022(Principal Investigator)
A phase 3, multicenter, open-label study to evaluate the safety of AGN-151586 for the treatment of glabellar lines March 2022- Oct2023(Principal Investigator)
Prospective, multicenter, controlled, evaluator-blind, randomized study to investigate the effectiveness and safety of diluted RADIESSE® for treatment of décolleté wrinkles. December 2021-Jan 2024 (Principal Investigator)
Clinical Study to Assess Efficacy and Tolerability of Skincare Regimen and Self-Administered Spot Peel for Moderate to Severe Solar Lentigines on the Facial Skin. September 2021-December 2021 (Principal Investigator)
Adaptation and Content Confirmation of Patient-Reported Outcome Measures in Cellulite. October 2021-December 2021 (Principal Investigator)
Patient-Reported Outcome Support for Galderma’s Clinical Trial Program for Décolletage. June 2021-July 2021 (Principal Investigator)
A prospective, evaluator- blind, multicenter study to assess the safety and effectiveness of treatment with the Octave System for lifting the eyebrow and improving the appearance of the face and neck. May 2021-Feb 2023(Principal Investigator)
The CONFIRM Study: A Multi-Center Pilot Study to Evaluate the Safety and Efficacy of the NuvellusTMFocal Contouring System on Submental Contouring. April 2021- July 2022 (Principal Investigator)
A prospective, evaluator- blind, multicenter study to assess the safety and A randomized, evaluator-blinded, no-treatment controlled, multicenter study to evaluate the effectiveness and safety of GAL1906 for correction of wrinkles in the décolletage area. January 2021-September 2022 (Principal Investigator)
Evaluation of Effectiveness and Safety of Belotero Balance (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow. September 2020-September 2022 (Principal Investigator)
A Single Center, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris. Feb 2020- Jan2021(Principal Investigator)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines (READY - 1). January 2020- July 2021 (Principal Investigator)
The INFORM Study: A Multi-Center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring with an Optimized Post-Procedure Treatment Plan. November 2019- July 2020 (Principal Investigator)
Development of ClinRO and PRO Instruments for Facial Lines January 2019-January 2020 (Principal Investigator)
A Randomized, Evaluator-Blinded, Parallel, Comparator-Controlled Study to Evaluate the Safety and Effectiveness of GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies December 2018-June 2020 (Principal Investigator)
A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo- Controlled Study to Evaluate the Safety and Efficacy of AbobutulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines. November 2018-July 2020 (Principal Investigator)
A Double-Blind Randomized Controlled Trial, Evaluating the Efficacy and Tolerability of the Alastin TransFORM Body Product in Combination with Cryolipolysis Procedures. Sep 2018-Sep 2019 (Principal Investigator)
A Randomized, No-Treatment- Controlled, Evaluator Blinded, Multi-Center Study to Evaluate the Effectiveness and Safety of Restylane® Defyne in the Chin for Augmentation and Correction of Chin Retrusion. August 2018-March 2020(Principal Investigator)
Evaluation of Effectiveness of Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the Jawline. July 2018- July 2020 (Principal Investigator)
A Single-Center, Split-Face, Randomized, Investigator-Blind Pilot Study to Compare the Efficacy and Tolerability of Two Post-Procedure Skin Care Regimens on Subjects with a Pre-Elected Intense Pulse Light (IPL) Laser Treatment. March 2018-August 2018 (Principal Investigator)
Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients. March 2018-November 2018 (Principal Investigator)
Evaluation of Alastin Regenerating Body Complex in Combination with CoolSculpting Treatment. February 2018-October 2018 (Principal Investigator)
Evaluation of the Lutronic Infini and LaseMD Systems in Combination Treatment” December 2017-July 2018 (Principal Investigator)
Pilot Evaluation of the Lutronic LaseMD System for Treatment of Dermatologic Conditions. April 2017-October 2017 (Principal Investigator)
Radiesse Post Approval Safety Study for the Treatment of Hands with Moderate to Very Severe Dorsal Volume Loss. June 2016-June 2019 (Principal Investigator)
A Prospective, Multi-center, Randomized, Evaluator-blinded, Split-hand Study to Evaluate the Effectiveness and Safety of Restylane® Lyft with Lidocaine Compared to No Treatment for Injection in the Dorsal Hand to Correct Volume Deficit. December 2015-March 2017 (Principal Investigator)
Radiesse® Post Approval Safety Study – Radiological Evaluation of Implantation in the Hands. November 2015- July 2018 (Principal Investigator)
Evaluation of the Safety and Efficacy of an Extended Treatment Protocol for the Improvement in the Contour of the Abdomen and Flanks (love handles) and Circumferential Reduction using a Non-Contact Radiofrequency Device. Jul 2014- Jan 2015 (Principal Investigator)
A Prospective, Randomized, Controlled, Multi-Center study of the safety and effectiveness of Juvederm Ultra XC Injectable Gel vs Belotero Balance for the Perioral Lines. October 2013-July 2014 (Principal Investigator)
A Blinded Split-Face Comparison of Post-Injection Local Adverse Events between Belotero®, Belotero® with Lidocaine and Belotero® with Lidocaine and Epinephrine. Apr 2013 (Principal Investigator)
Evaluation of Radiesse Dermal Filler for Hand Treatment 2013-2014 (Principal Investigator)
A Randomized, Evaluator-Blinded, No-Treatment-Controlled Study of the Effectiveness and Safety of Perlane-L in the Correction of Midface Volume deficit and/or Midface Contour Deficiency. 2012-2014. (Principal Investigator)
A Prospective, Open-Label Evaluator-Blinded Study of Small Gel Particle Hyaluronic Acid (SGP-HA) Filler, Perlane-L, in the Correction of Temporal Fossa Volume Loss. 2011 (Principal Investigator)
An Open Label Study of the Safety of Restylane-L and Perlane-L in the Correction of Perioral Wrinkles. 2011 (Principal Investigator)
A non-interventional observational and medical records review of patient outcomes with bimatoprost ophthalmic solution 0.03% (Latisse) for treatment of hypotrichosis of the eyelashes. 2011 (Principal Investigator)
Outcome research on Chronic Sinusitis and Antibiotic treatment 1998 VA Hospital Durham, NC, Amir Moradi, MD, David Witsel
Effect of IGF-B on Nasophar2011 (ngio Fibroma” UCSD School of Medicine; 1993-94, Amir Moradi, Andrew Baird
Evaluating the sense of Taste in patients post mastoidectomy and injury to Chorda Tympani Nerve. University of California San Diego School of Medicine; 1993, Amir Moradi, Mark Whitehead
Retrospective Evaluation; Pediatric patients at UCSD Medical Center, correlation between HIV and Sinonasal disease. 1992, Amir Moradi, Anthony Magid
Evaluation of Alzheimer brain for changes associated with disease progression. University of California San Diego; Aging Research 1988, Amir Moradi, Edmond Siegmiler

Schedule a Consultation

Publications

Suchomlinov A, Noel G, Moradi A. An atypical anatomical variation in facial nerve position: temporal branch lateral and main trunk medial to the retromandibular vein in a series of three cadaveric cases with clinical implications. Laryngoscope Investigative Otolaryngology. 2025;10(4):e70233. doi:10.1002/lio2.70233.
Moradi A., Kim J., Kim J., Brieva P., Yan X. Clinical Efficacy of a Flavo-Proxylane Topical Regimen Pre- and Post-Ultrasound Procedure for Subjects Undergoing Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Therapy. Poster presented at the European Academy of Dermatology and Venereology (EADV) Congress; Paris, France. (Accepted for presentation)
Bachelor, Eric MD*; Moradi, Amir MD†; Stevens, Grant MD‡; Scott-Shemon, Deja MPH§; Ostrowski, Rafael‖; Madere, Tonia CCRP‖; Gamio, Sylvia MSc, CCRP‖. Safety, Effectiveness, and Participant Satisfaction With Multiple Simultaneous Cryolipolysis Treatments Using a Dual-Applicator Cryolipolysis System. Dermatologic Surgery ():10.1097/DSS.0000000000004574, February 11, 2025. | DOI: 10.1097/DSS.0000000000004574
Moradi A, Montes JR, Humphrey S, Grunebaum LD, Bertossi D, Dimitrijevic E, Sangha S. A unified approach to facial contours and volume correction: the role of the cheek and the chin. Plast Reconstr Surg Global Open. 2024;12(10):e6219.
Moradi A, Daković R. Plain language summary of the pivotal study of calcium hydroxylapatite with lidocaine for improvement of jawline contour. J Dermatolog Treat. 2024;35(1):2421435.
Green JB, Del Campo R, Durkin AJ, et al. Long-term duration and safety of Radiesse (+) for the treatment of jawline. J Cosmet Dermatol. 2024; 00: 1–8. doi:10.1111/jocd.16436
Moradi A, Shafiq F, Robison T, Colvan L, Poehler J, Widgerow AD. "Multicenter evaluation of a topical antioxidant serum." J Cosmet Dermatol. 2024; 23: 145–153. doi:10.1111/jocd.16067
Validation of a midfacial scale and its use in a randomized, evaluator-blinded Study of CPM-HA-V. JDD. Jan 2024
Moradi A, Đakovic R, Odena G. "Aesthetic implantation of calcium hydroxylapatite does not interfere with radiological assessment of bones in the dorsum of the hands." Aesthetic Surgery Journal. 2023; 43(6): 696–703
Moradi A, et al. "Multicenter evaluation of a topical antioxidant serum." J Cosmet Dermatol. 2023
Moradi A, et al. "Guidelines for optimal patient outcomes using calcium hydroxylapatite for jawline contour." Aesthetic Surgery Journal Open Forum. Vol. 5. 2023
Moradi A, et al. "Effectiveness and safety of calcium hydroxylapatite with lidocaine for improving jawline contour." J Drugs Dermatol. 2021; 20(11): 1231–1238
Marcus K, Moradi A, et al. "A randomized trial to assess effectiveness and safety of a hyaluronic acid filler for chin augmentation and correction of chin retrusion." Plast Reconstr Surg. 2022; 150(6): 1240
Chao K, Moradi A, Khalifian S. "DaxibotulinumtoxinA for injection: A review of the current data." Dermatol Rev. 2022; 3(4): 221–230
Jones D, et al. "A randomized, comparator-controlled study of HARC for cheek augmentation and correction of midface contour deficiencies." J Drugs Dermatol. 2021; 20(9): 949–956
Moradi A, et al. "Electromagnetic muscle stimulation: A retrospective study of patient experience." J Cosmet Dermatol. 2022; 21(1): 271–278
Moradi A, Shirazi A. "A retrospective and anatomical study describing the injection of botulinum neurotoxins in the depressor anguli oris." Plast Reconstr Surg. 2022; 149(4): 850–857
Comer JD, Translational Lecture Series, Derm Atlas. "AbobotulinumtoxinA for glabellar lines: A randomized, dose-escalating, double-blind study."
Dayan S, et al. "Subject satisfaction and psychological well-being with escalating abobotulinumtoxinA injection dose for glabellar lines." J Cosmet Dermatol. 2022; 21(6): 2407–2416
Janes LE, et al. "Current use of cosmetic toxins to improve facial aesthetics." Plast Reconstr Surg. 2021; 147(4): 644e–657e
Moradi A, et al. "Validation of photonumeric assessment scales for temple volume deficit, infraorbital hollows, and chin retrusion." Dermatol Surg. 2020; 46(9): 1148–1154
Moradi A, Poehler J, Bell M. "Double-blind trial of TriHex Technology® body treatment with cryolipolysis or RF." J Cosmet Dermatol. 2020; 19(3): 677–681
Jones DH, Swift A, eds. Injectable Fillers: Facial Shaping and Contouring. Wiley. 2019
Poehler J. "Topical body treatment with cryolipolysis: RCT." J Drugs Dermatol. 2019; 18(4): 342–348
Galderma Chin Retrusion Scale Poster: AMWC Conference, Monaco. 2019
The Mandible, Jawline, and Chin. Injectable Fillers: Facial Shaping and Contouring. 2019: 165–173
Moradi A, Shirazi A, David R. "Nonsurgical chin and jawline augmentation with CaHA and HA fillers." Facial Plast Surg. 2019; 35(2): 140–148
Moradi A, et al. "Split-hand study of HA with lidocaine for dorsal hand correction." Plast Reconstr Surg. 2019; 144(4): 586
Goldman MP, et al. "CaHA for dorsal hand volume: 12-month RCT." Dermatol Surg. 2018; 44(1): 75–83
Moradi A, et al. "HA with lidocaine for hand volume: RCT." Plast Reconstr Surg Glob Open. 2018; 6(9 Suppl)
Moradi A, Martin K, Poehler J. "HI-FRM and fractional laser combo for face/neck rejuvenation." Plast Reconstr Surg Glob Open. 2018; 6.85: 160–161
Weiss RA, et al. "HA with lidocaine for midface volume correction." Dermatol Surg. 2016; 42(6): 699–709
Moradi A, Watson J. "Current concepts in filler injection." Facial Plast Surg Clin North Am. 2015; 23(4): 489–494
Sykes JM, et al. "Upper face: clinical anatomy and regional filler techniques." Plast Reconstr Surg. 2015; 136(5): 204S–218S
Lefebvre-Vilardebo M, et al. "Hand: clinical anatomy and filler techniques." Plast Reconstr Surg. 2015; 136(5): 258S–275S
Moradi A, et al. "Split-face pilot of bruising/pain with HA for perioral lines." Aesthet Surg J. 2015; 35(4): 443–455
Moradi A, Palm M. "Extended field radiofrequency safety/efficacy protocol." J Drugs Dermatol. 2015; 14(9): 982–985
"Occipitofrontalis muscle anatomy for botulinum toxin." Aesthet Surg J. 2013; 37(5): 975–983
Moradi A. "SGP-HA for temporal fossa volume loss." J Drugs Dermatol. 2013; 12(4): 470–475
Maas C, et al. "Consensus on abobotulinumtoxinA in practice." Aesthet Surg J. 2012; 32(1 Suppl): 8S–29S
Moradi A, Shirazi A, Perez V. "Temporal fossa augmentation with SGP-HA filler." J Drugs Dermatol. 2011; 10(6): 673–676